When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about ...

Learn why ADMA Biologics looked undervalued near $2 in 2021—asset value, revenue growth, insider buying, and a path to ...

In the latest trading session, Adma Biologics (ADMA) closed at $17.7, marking a -1.28% move from the previous day.

ADMA expects 2025 revenues of approximately $510-$511 million, raising 2026 guidance on strong Asceniv demand and margin ...

Shares of Super Micro Computer have surged since the company's IPO, and the stock's forecast should catch investors' ...

As the marketplace for semiconductors grows beyond Nvidia, Broadcom—a major competitor—should see its stock price grow ...

Of course, the No. 1 driver of AMD's stock performance (at least in recent years) is the surge in AI investment. The largest tech companies plan to invest hundreds of billions of dollars in AI ...

Analysts are saying that Northrop Grumman could rise by 2030. Bullish on NOC? Invest in Northrop Grumman on SoFi with no commissions. If it’s your first time signing up for SoFi, you’ll receive up to ...

Robinhood's platform allows investors to buy and sell stocks, options, futures, and cryptocurrencies. The company entered the prediction markets business earlier this year, which contributed to the ...

In the latest close session, Adma Biologics (ADMA) was up +1.72% at $18.34. This change outpaced the S&P 500's 0.62% gain on the day. At the same time, the Dow added 0.99%, and the tech-heavy Nasdaq ...

The S&P 500 just completed its third consecutive year of double-digit gains. AI stocks have pushed the index higher amid excitement about this hot technology. It's that time again... The year 2025 has ...

Marvell Technology (NASDAQ: MRVL) is strengthening its position in AI infrastructure as demand for high-speed data movement and efficient power delivery accelerates. With a record quarter, new ...